Shots:
Kathy spoke about the major outcomes from the real-world evidence data presented at the ASCO 2022
Kathy also emphasized on how next-generation sequencing can improve genomic testing
The interview gives a view of Thermo Fisher’s vision to bring targeted sequencing that provides faster results for clinicians
Smriti: Tell us in detail about the key…
